These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Flosequinan and arrhythmogenesis. Noble J; Farrer M; McComb JM Lancet; 1993 Apr; 341(8852):1100. PubMed ID: 8097002 [No Abstract] [Full Text] [Related]
3. Ventricular arrhythmias associated with flosequinan. Carson JJ; Lober CA; Turi AR Ann Pharmacother; 1994 Mar; 28(3):403-4. PubMed ID: 8193436 [No Abstract] [Full Text] [Related]
4. The flosequinan experience and its implications. Fath-Ordoubadi F Br J Hosp Med; 1993 Dec 15-1994 Jan 18; 50(11):683; author reply 683-4. PubMed ID: 8124555 [No Abstract] [Full Text] [Related]
5. Flosequinan for chronic heart failure? Drug Ther Bull; 1993 Jun; 31(12):47-8. PubMed ID: 8344139 [No Abstract] [Full Text] [Related]
7. Possible role of metabolite in flosequinan-related mortality. Kamali F; Edwards C Clin Pharmacokinet; 1995 Dec; 29(6):396-403. PubMed ID: 8787946 [No Abstract] [Full Text] [Related]
8. Effects of concurrent administration of flosequinan and digoxin on the pharmacokinetics of each drug. Rau R; Hind ID; Wynne RD; White SA Arzneimittelforschung; 1994 Mar; 44(3):300-4. PubMed ID: 8192694 [TBL] [Abstract][Full Text] [Related]
9. The effects of flosequinan and nifedipine on glucose tolerance in healthy volunteers. Lewis H; Kendall M; Bratty JR J Clin Pharm Ther; 1988 Aug; 13(4):269-72. PubMed ID: 3235476 [TBL] [Abstract][Full Text] [Related]
10. A non-invasive evaluation of flosequinan on haemodynamics and exercise capacity in chronic congestive heart failure. Motro M; Freimark D; Feinberg MS; Wynne RD; King C; Schneeweiss A Int J Clin Pharmacol Res; 1993; 13(3):143-9. PubMed ID: 8225697 [TBL] [Abstract][Full Text] [Related]
15. [Letter: Possible responsibility of a peripheral vasodilator agent, fenoxedil, in the occurrence of heart rhythm disorders]. Barraine R; Ariès J; Druart F; Casteigt JM; Benabbou M; Valois M; Marin J; Demange J; Rousseau G Nouv Presse Med; 1975 Dec; 4(42):3008-9. PubMed ID: 1221355 [No Abstract] [Full Text] [Related]
16. [A new drug against heart failure was retracted after an alarm about increased mortality]. Lennholm B Lakartidningen; 1993 Aug; 90(32-33):2682-3. PubMed ID: 8361279 [No Abstract] [Full Text] [Related]
17. K+ channel opening: a new drug principle in cardiovascular medicine. Gussak I; Bjerregaard F Heart; 1997 May; 77(5):487. PubMed ID: 9196426 [No Abstract] [Full Text] [Related]
18. [Heart rhythm disorders as a result of therapy]. Sangiorgi M; Cannata D Z Gesamte Inn Med; 1983 Jun; 38(12):93-6 contd. PubMed ID: 6613211 [No Abstract] [Full Text] [Related]
19. Cardiac imaging studies: are there possible risks? Valentinuzzi ME Int J Cardiol; 2013 Sep; 168(2):1636. PubMed ID: 23498285 [No Abstract] [Full Text] [Related]